Delta relaxation enhanced mr: Improving activation - Speeificity of molecular probes through R1 dispersion imaging

Magnetic Resonance in Medicine

Volumn 61, Issue 4, 2009, Pages 796-802

  Alford, Jamu K ^a   Rutt, Brian K ^a,b,c   Scholl, Timothy J ^a   Handler, William B ^a   Chronik, Blaine A ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c Chaires de recherche du Canada   (Canada)

Author keywords

Albumin; Delta relaxation enhanced MR; Molecular probes; Vasovist

Indexed keywords

MAGNETIC FIELDS; MOLECULAR IMAGING; MOLECULES; PROBES;

ALBUMIN; BIOLOGICAL MOLECULE; DELTA RELAXATION ENHANCED MR; DISPERSION IMAGING; MAGNETIC FIELD STRENGTHS; MOLECULAR PROBES; PARTIAL DERIVATIVES; VASOVIST;

IMAGE ENHANCEMENT;

ALBUMIN; BUFFER; GADOFOSVESET;

ARTICLE; DELTA RHYTHM; DIAGNOSTIC IMAGING; DISPERSION; IMAGE DISPLAY; IMAGE ENHANCEMENT; MAGNETIC FIELD; MOLECULAR IMAGING; MOLECULAR PROBE; NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY;

EID: 66249091924     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21933     Document Type: Article

References (19)

1. Weissleder R. Mahmood U. Molecular imaging. Radiology 2001;219: 316-333.
2. Nahrendorf M. Sosnovik D. E. Weissleder R. MR-optical imaging of cardiovascular molecular targets. Basic Res Cardiol 2008;103;87-94.
3. Hendrick R. E. Haacke EM. Basic physics of MR contrast agents and maximization of image contrast. J Magn Reson Imaging 1993:3:137-148.
4. Wood M. L. Hardy PA. Proton relaxation enhancement, J Magn Reson Imaging 1993;3:149-156.
5. Caravan P. Cloutier N. J. Greenfield M. T. McDermid S. A. Dunham S. U. Bulte J. W. Amedio J. G. Jr. Looby R. J. Supkowski R. M. Horrocks W. D. Jr. McMurry T. J. Lauffer RB. The interaciion of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc 2002;124:3152-3182.
6. Henrotte V. Vander Elst L. Laurent S. Muller RN. Comprehensive investigation of the non-covalent binding of MRI contrast agents with human serum albumin. J Biol Inorg Chem 2007;12:929-937.
7. Eldredge FIB, Spiller M. Chasse J. M. Greenwood M. T. Caravan P. Species dependence on plasma protein binding and relaxivity of the gadolinium-based MRI contrast agent MS-325. Investig Radiol 2006;41:229-243.
8. Nahrendorf M. Sosnovik D. Chen JW. Panizzi P. Figueiredo J. L. Aikawa E. Libby P. Swirski F. K. Weissleder R. Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. Circulation 2008;117:1153-1160.
9. Overoye-Chan K. Koerner S. Looby R. J. Kolodziej A. F. Zech S. G. Deng Q. Chasse J. M. McMurry T. J. Caravan P. EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus. J Am Chem Soc 2008:130:6025-6039.
10. Alford JK. Delta relaxation enhanced MR (dreMR): Theory of T1-slope weighted contrast. In: Proc ISMRM, Toronto: 2008.
11. Carlson J. W. Goldliaber D. M. Brito A. Kaufman L. MR relaxometry Imaging. Work in progress. Radiology 1992;184:635-639.
12. Ungersma S. E. Matter N. I. Hardy J. W. Venook R. D. Macovski A. Conolly SM. Scott GG. Magnetic resonance imaging with T1 dispersion contrast. Magn Reson Med 2006;55:1362-1371.
13. Bottomley P. A. Foster T. H. Argerslnger R. E. Pfeifer LM. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. Med Phys 1984;11: 425-448.
14. Henriksen O. de Gertaines J. D. Spisni A. Gortsen M. Muller R. N. Ring PB. In vivo field dependence of proton relaxation times in human brain, liver and skelet al. muscle: a multicenter study. Magn Reson Imaging 1993;11:851-856.
15. Zhou X. Caravan P. Clarkson R. B. Westhund PO. On the philosophy of optimizing contrast agents. An analysis of Hi NMRD profiles and ESR lineshapes of the Gd (III) complex MS-325-+-HSA. J Magn Reson 2004; 167:147-160.
16. Gilbert K. M. Handler W. B. Scholl T. J. Odegaard J. W. Chronik BA. Design of field-cycled magnetic resonance systems for small animal imaging. Phys Med Biol 2006;51:2025-2841.
17. Matter N. I. Scott G. G. Grafendorfer T. Macovski A. Gonolly SM. Rapid polarizing held cycling In magnetic resonance imaging. IEEE Trans Med Imaging 2006;25:84-93.
18. Lurie D. J. Foster MA. Yeung D. Hutchison JM. Design, construction and use of a large-sample field-cycled PEDRI imager. Phys Med Biol 1998; 43:1877-1886.
19. Alford J. From static to dynamic: construction of an actively shielded B0 coil for field-cycled imaging with clinical MR platforms. In: Proc ISMRM, Toronto; 2008.